Mr. Saleem may also be worried that information relating to the transference of 50+million shares to entities such as Total Care and the direct sale (which does not show up on L2) of 40+ million shares to private investors will be publicized. Mr. Saleem sent an email to me and two other investors claiming that no director, current or former, besides Mr. Kakani, sold shares. Unfortunately for Mr. Saleem, records of all transactions exist. In addition, Mr. Kakani disputes Mr. Saleem’s allegation and I believe that documentation will prove that Mr. Kakani is telling the truth and that Mr. Saleem is, once again, providing materially false information to investors. There is also a question regarding the ownership of shares that were purportedly sold by Mr. Saleem; those shares may have been in the name of current or former officers. If so, were they aware of what was being done? Did they ‘turn a blind eye’?
Likewise, Mr. Saleem may be worried that PR's relating to the existence and transfer of funds were provided to investors even though said claims were false and/or misleading. Making material misrepresentations to the public in order to induce the purchase of securities is highly frowned upon. In fact, it is illegal. Again, did current or former officers of the company know what was occurring? Given their responsibilities as officers of the company they are responsible for actions taken during their stewardship of the company. If they did know, or if they ‘turned a blind eye’, it will be even harder for them to escape prosecution. (Having a letter of ‘indemnification’ from Mr. Saleem will not do them a bit of good in a court of law.)
IMHO, Mr. Saleem has, along with current and former officers of Michelex, much more to worry about than the supposed profitability of certain contracts that were fulfilled by Pristine Pharma Corporation. Especially since correspondence will show that Mr. Saleem’s ‘concern’ is fraudulent, and that, once again, he is providing materially false information to investors.
AI
